114 related articles for article (PubMed ID: 11847436)
1. From cDNA microarrays to high-throughput proteomics. Implications in the search for preventive initiatives to slow the clinical progression of Alzheimer's disease dementia.
Pasinetti GM; Ho L
Restor Neurol Neurosci; 2001; 18(2-3):137-42. PubMed ID: 11847436
[TBL] [Abstract][Full Text] [Related]
2. From proteomics to biomarker discovery in Alzheimer's disease.
Ho L; Sharma N; Blackman L; Festa E; Reddy G; Pasinetti GM
Brain Res Brain Res Rev; 2005 Apr; 48(2):360-9. PubMed ID: 15850675
[TBL] [Abstract][Full Text] [Related]
3. Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia.
Pasinetti GM
J Neurosci Res; 2001 Sep; 65(6):471-6. PubMed ID: 11550214
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease biomarker discovery in symptomatic and asymptomatic patients: experimental approaches and future clinical applications.
Ho L; Fivecoat H; Wang J; Pasinetti GM
Exp Gerontol; 2010 Jan; 45(1):15-22. PubMed ID: 19796674
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer's disease: A literature review.
Wesenhagen KEJ; Teunissen CE; Visser PJ; Tijms BM
Crit Rev Clin Lab Sci; 2020 Mar; 57(2):86-98. PubMed ID: 31694431
[TBL] [Abstract][Full Text] [Related]
6. Systems biology in the study of neurological disorders: focus on Alzheimer's disease.
Pasinetti GM; Hiller-Sturmhöfel S
Alcohol Res Health; 2008; 31(1):60-5. PubMed ID: 23584752
[TBL] [Abstract][Full Text] [Related]
7. cDNA microarray and proteomic approaches in the study of brain diseases: focus on schizophrenia and Alzheimer's disease.
Marcotte ER; Srivastava LK; Quirion R
Pharmacol Ther; 2003 Oct; 100(1):63-74. PubMed ID: 14550505
[TBL] [Abstract][Full Text] [Related]
8. Microarray analysis in Alzheimer's disease and normal aging.
Ricciarelli R; d'Abramo C; Massone S; Marinari U; Pronzato M; Tabaton M
IUBMB Life; 2004 Jun; 56(6):349-54. PubMed ID: 15370883
[TBL] [Abstract][Full Text] [Related]
9. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
10. Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?
Moya-Alvarado G; Gershoni-Emek N; Perlson E; Bronfman FC
Mol Cell Proteomics; 2016 Feb; 15(2):409-25. PubMed ID: 26657538
[TBL] [Abstract][Full Text] [Related]
11. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
Farina N; Llewellyn D; Isaac MGEKN; Tabet N
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002854. PubMed ID: 28418065
[TBL] [Abstract][Full Text] [Related]
12. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
Farina N; Llewellyn D; Isaac MG; Tabet N
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002854. PubMed ID: 28128435
[TBL] [Abstract][Full Text] [Related]
13. Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients.
Di Domenico F; Pupo G; Giraldo E; Badìa MC; Monllor P; Lloret A; Schininà ME; Giorgi A; Cini C; Tramutola A; Butterfield DA; Viña J; Perluigi M
Free Radic Biol Med; 2016 Feb; 91():1-9. PubMed ID: 26675344
[TBL] [Abstract][Full Text] [Related]
14. Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults.
Dayon L; Wojcik J; Núñez Galindo A; Corthésy J; Cominetti O; Oikonomidi A; Henry H; Migliavacca E; Bowman GL; Popp J
J Alzheimers Dis; 2017; 60(4):1641-1652. PubMed ID: 29125490
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of serum proteins in triple transgenic Alzheimer's disease mice: implications for identifying biomarkers for use to screen potential candidate therapeutic drugs for early Alzheimer's disease.
Sui X; Ren X; Huang P; Li S; Ma Q; Ying M; Ni J; Liu J; Yang X
J Alzheimers Dis; 2014; 40(3):575-86. PubMed ID: 24496070
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique.
Ho L; Guo Y; Spielman L; Petrescu O; Haroutunian V; Purohit D; Czernik A; Yemul S; Aisen PS; Mohs R; Pasinetti GM
Neurosci Lett; 2001 Feb; 298(3):191-4. PubMed ID: 11165439
[TBL] [Abstract][Full Text] [Related]
17. Harnessing the power of gene microarrays for the study of brain aging and Alzheimer's disease: statistical reliability and functional correlation.
Blalock EM; Chen KC; Stromberg AJ; Norris CM; Kadish I; Kraner SD; Porter NM; Landfield PW
Ageing Res Rev; 2005 Nov; 4(4):481-512. PubMed ID: 16257272
[TBL] [Abstract][Full Text] [Related]
18. Preliminary studies on Alzheimer's disease using cDNA microarrays.
Wang G; Zhang Y; Chen B; Cheng J
Mech Ageing Dev; 2003 Jan; 124(1):115-24. PubMed ID: 12618014
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
